Arcus Biosciences
RCUS
RCUS
187 hedge funds and large institutions have $948M invested in Arcus Biosciences in 2023 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 73 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.94% less ownership
Funds ownership: 74.82% → 70.89% (-3.9%)
15% less capital invested
Capital invested by funds: $1.11B → $948M (-$162M)
27% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 73
Holders
187
Holding in Top 10
3
Calls
$22.6M
Puts
$15.9M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$10.7M | |
| 3 | +$5.47M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.33M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.99M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$15.2M | |
| 3 | -$12.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.07M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.5M |